Graviti Pharms Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for GRAVITI PHARMS, and what generic and branded alternatives to GRAVITI PHARMS drugs are available?
GRAVITI PHARMS has eighteen approved drugs.
Drugs and US Patents for Graviti Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Graviti Pharms | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211020-002 | Jan 28, 2019 | AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Graviti Pharms | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 209912-002 | Jun 18, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Graviti Pharms | MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 209012-001 | Apr 24, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Graviti Pharms | GABAPENTIN | gabapentin | CAPSULE;ORAL | 207099-001 | Mar 24, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.